Avalo Therapeutics, Inc.

AVTXNasdaq· Pharmaceutical Preparations

Price History

Revenue

$59,000

▼ 86.6% YoY

Net Income

-$78.3M

▼ 122.8% YoY

EPS

$-5.84

▲ 72.1% YoY

Cash

$15.9M

▼ 88.2% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.